Bamba Salia, Sidibé Lala, Diallo Seybou H, Cissé Lassana, Dembélé Kékouta, Yalcouyé Abdoulaye, Ji Weizhen, Dembélé Mohamed Emile, Diarra Salimata, Maiga Alassane Dit Baneye, Traoré Oumou, Diallo Salimata, Mefoung Samuel Ephrata, Touré Amadou, Koné Adama, Jeffries Lauren, Guinto Cheick O, Mis Emily K, Fischbeck Kenneth H, Khokha Mustafa K, Lakhani Saquib A, Landouré Guida
Faculté de Médecine et d'Odontostomatologie, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali.
Pediatric Genomics Discovery Program (PGDP), Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States.
Front Genet. 2024 Nov 18;15:1412442. doi: 10.3389/fgene.2024.1412442. eCollection 2024.
Developmental and epileptic encephalopathies (DEEs) are a group of neurological disorders characterized by early-onset seizures that are often resistant to treatment, by electroencephalographic abnormalities, and by developmental delay or regression. Their genetic basis remains largely unelucidated, especially in sub-Saharan Africa (SSA). We investigated the genetic bases of DEE in three Malian families.
Patients underwent clinical evaluation, and DNA was obtained for whole exome sequencing (WES). Putative variants were screened in all available family members and prediction analyses were performed to assess pathogenicity.
Five patients from three unrelated families with DEEs had symptoms that started during the neonatal period with seizures and myoclonus that became refractory to antiepileptic medications. WES identified previously unreported variants in all three families: homozygous variants in and and compound heterozygous variants in . These variants affected protein structure by tools and were classified as variants of uncertain significance hot, pathogenic/likely pathogenic respectively according to ACMG criteria.
We identified rare variants in three genes ( and ) associated with early onset of DEEs in SSA, expanding their genetic and epidemiological spectrum. Larger cohort studies in SSA may unravel more variants with potential clinical implications and further our understanding of the disease mechanism.
发育性和癫痫性脑病(DEEs)是一组神经疾病,其特征为起病早且常为难治性癫痫发作、脑电图异常以及发育迟缓或倒退。其遗传基础在很大程度上仍未阐明,尤其是在撒哈拉以南非洲(SSA)地区。我们对三个马里家庭的DEE遗传基础进行了研究。
对患者进行临床评估,并获取DNA进行全外显子组测序(WES)。在所有可用家庭成员中筛选推定的变异,并进行预测分析以评估致病性。
来自三个无关家庭的五名患有DEEs的患者在新生儿期开始出现癫痫发作和肌阵挛症状,对抗癫痫药物变得难治。WES在所有三个家庭中均鉴定出先前未报道的变异:两个家庭中为纯合变异,一个家庭中为复合杂合变异。这些变异通过工具影响蛋白质结构,并根据美国医学遗传学与基因组学学会(ACMG)标准分别分类为意义未明的热点变异、致病/可能致病变异。
我们在三个基因(两个基因名未给出)中鉴定出与SSA地区DEEs早发相关的罕见变异,扩展了其遗传和流行病学谱。在SSA地区开展更大规模的队列研究可能会发现更多具有潜在临床意义的变异,并进一步加深我们对疾病机制的理解。